304 related articles for article (PubMed ID: 6496367)
1. Effect of propafenone in the Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Breithardt G; Borggrefe M; Wiebringhaus E; Seipel L
Am J Cardiol; 1984 Nov; 54(9):29D-39D. PubMed ID: 6496367
[TBL] [Abstract][Full Text] [Related]
2. Usefulness of programmed stimulation in predicting efficacy of propafenone in long-term antiarrhythmic therapy for paroxysmal supraventricular tachycardia.
Manz M; Steinbeck G; Lüderitz B
Am J Cardiol; 1985 Oct; 56(10):593-7. PubMed ID: 4050693
[TBL] [Abstract][Full Text] [Related]
3. Efficacy of propafenone in Wolff-Parkinson-White syndrome: electrophysiologic findings and long-term follow-up.
Ludmer PL; McGowan NE; Antman EM; Friedman PL
J Am Coll Cardiol; 1987 Jun; 9(6):1357-63. PubMed ID: 3294970
[TBL] [Abstract][Full Text] [Related]
4. Electrophysiologic effects of oral propafenone in Wolff-Parkinson-White syndrome studied by programmed electrical stimulation.
Sethi KK; Prasad GS; Mohan JC; Arora R; Khalilullah M
Indian Heart J; 1991; 43(1):5-10. PubMed ID: 1894303
[TBL] [Abstract][Full Text] [Related]
5. Electrophysiologic effects of lorcainide on the accessory pathway in the Wolff-Parkinson-White syndrome.
Kasper W; Treese N; Meinertz T; Jähnchen E; Pop T
Am J Cardiol; 1983 Jun; 51(10):1618-22. PubMed ID: 6858867
[TBL] [Abstract][Full Text] [Related]
6. Electrophysiologic effects of intravenous propafenone in Wolff-Parkinson-White syndrome.
Dubuc M; Kus T; Campa MA; Lambert C; Rosengarten M; Shenasa M
Am Heart J; 1989 Feb; 117(2):370-6. PubMed ID: 2644795
[TBL] [Abstract][Full Text] [Related]
7. Clinical efficacy and electrophysiologic effects of encainide in patients with Wolff-Parkinson-White syndrome.
Prystowsky EN; Klein GJ; Rinkenberger RL; Heger JJ; Naccarelli GV; Zipes DP
Circulation; 1984 Feb; 69(2):278-87. PubMed ID: 6418407
[TBL] [Abstract][Full Text] [Related]
8. Limited role of intravenous propafenone hydrochloride in the treatment of sustained ventricular tachycardia: electrophysiologic effects and results of programmed ventricular stimulation.
Doherty JU; Waxman HL; Kienzle MG; Cassidy DM; Marchlinski FE; Buxton AE; Josephson ME
J Am Coll Cardiol; 1984 Aug; 4(2):378-81. PubMed ID: 6736479
[TBL] [Abstract][Full Text] [Related]
9. Clinical efficacy and electrophysiology of oral propafenone for ventricular tachycardia.
Connolly SJ; Kates RE; Lebsack CS; Echt DS; Mason JW; Winkle RA
Am J Cardiol; 1983 Dec; 52(10):1208-13. PubMed ID: 6359849
[TBL] [Abstract][Full Text] [Related]
10. Electrophysiologic effects and clinical efficacy of oral propafenone therapy in patients with ventricular tachycardia.
Chilson DA; Heger JJ; Zipes DP; Browne KF; Prystowsky EN
J Am Coll Cardiol; 1985 Jun; 5(6):1407-13. PubMed ID: 3889099
[TBL] [Abstract][Full Text] [Related]
11. Encainide for treatment of atrioventricular reciprocating tachycardia in the Wolff-Parkinson-White syndrome.
Miles WM; Zipes DP; Rinkenberger RL; Markel ML; Prystowsky EN; Dougherty AH; Heger JJ; Naccarelli GV
Am J Cardiol; 1988 Dec; 62(19):20L-25L. PubMed ID: 3144163
[TBL] [Abstract][Full Text] [Related]
12. Ethmozin. I. Effects of intravenous drug administration on paroxysmal supraventricular tachycardia in the ventricular preexcitation syndrome.
Chazov EI; Shugushev KK; Rosenshtraukh LV
Am Heart J; 1984 Sep; 108(3 Pt 1):475-82. PubMed ID: 6382988
[TBL] [Abstract][Full Text] [Related]
13. Effects of verapamil on the electrophysiologic properties of the accessory pathway in patients with the Wolff-Parkinson-White syndrome.
Harper RW; Whitford E; Middlebrook K; Federman J; Anderson S; Pitt A
Am J Cardiol; 1982 Dec; 50(6):1323-30. PubMed ID: 7148709
[TBL] [Abstract][Full Text] [Related]
14. [Electrophysiologic properties of cibenzoline in Wolff-Parkinson-White syndrome and atrioventricular nodal reentry tachycardia].
Kühlkamp V; Ickrath O; Schmid F; Mayer F; Haasis R; Seipel L
Z Kardiol; 1989 Oct; 78(10):640-6. PubMed ID: 2686251
[TBL] [Abstract][Full Text] [Related]
15. Antiarrhythmic effects of selective prolongation of refractoriness. Electrophysiologic actions of sematilide HCl in humans.
Sager PT; Nademanee K; Antimisiaris M; Pacifico A; Pruitt C; Godfrey R; Singh BN
Circulation; 1993 Sep; 88(3):1072-82. PubMed ID: 8353869
[TBL] [Abstract][Full Text] [Related]
16. [Electrophysiologic effects and clinical efficacy of propafenone in pediatric patients with paroxysmal supraventricular reentrant tachycardia].
Musto B; D'Onofrio A; Musto A; Cavallaro C; Marsico F
G Ital Cardiol; 1986 Apr; 16(4):336-43. PubMed ID: 3743937
[TBL] [Abstract][Full Text] [Related]
17. Electrophysiologic and clinical effects of intravenous and oral encainide in accessory atrioventricular pathway.
Kunze KP; Kuck KH; Schlüter M; Kuch B; Bleifeld W
Am J Cardiol; 1984 Aug; 54(3):323-9. PubMed ID: 6431796
[TBL] [Abstract][Full Text] [Related]
18. [Effect of oral propafenon on accessory pathways of atrioventricular conduction].
Lacroix H; Frank R; Tonet JL; Fontaine G; Wajman A; Squeir S; Grosgogeat Y
Arch Mal Coeur Vaiss; 1985 Apr; 78(4):622-7. PubMed ID: 2860884
[TBL] [Abstract][Full Text] [Related]
19. European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias.
Coumel P; Leclercq JF; Assayag P
Am J Cardiol; 1984 Nov; 54(9):60D-66D. PubMed ID: 6208770
[TBL] [Abstract][Full Text] [Related]
20. Effects of propafenone on induction and maintenance of atrioventricular nodal reentrant tachycardia.
Garcia-Civera R; Sanjuan R; Morell S; Ferrero JA; Miralles L; Llavador J; Lopez-Merino V
Pacing Clin Electrophysiol; 1984 Jul; 7(4):649-55. PubMed ID: 6205364
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
